Delivery Order SPE2DR25D3016-SPE2DR26FG7MS
Award Date 4/23/26
Potential Completion Date 4/24/26
Potential Value $14K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $27,325.91 delivery order to Amerisourcebergen Drug Corp on April 2, 2026, for NURTEC ODT 75 mg tablets (8-count units), with an ultimate completion date of April 3, 2026. Place of performance is Conshohocken, PA. The order is priced on a firm fixed-price basis with no set-aside used. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal medical procurement, particularly for military and veteran...
- The Defense Logistics Agency issued a $8,329.57 delivery order to Amerisourcebergen Drug Corp on April 22, 2026, for NURTEC ODT 75 MG Tablet 8s, with ultimate completion on April 23, 2026. Place of performance is Conshohocken, PA. The order is firm fixed-price with no set-aside. Amerisourcebergen Drug Corp is a pharmaceutical distributor and medical supplier subsidiary of Cencora, Inc., competing on full-and-open competitive awards to the Defense Logistics Agency and federal healthcare...
- <p>The Defense Logistics Agency issued a $24,932.06 delivery order to Amerisourcebergen Drug Corp on April 20, 2026, for NURTEC ODT 75 mg tablets (8-count packaging), with an ultimate completion date of April 21, 2026.</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed-price with no set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. and operates as a pharmaceutical distributor supplying the Department of Defense and federal healthcare systems.</p>
- The Defense Logistics Agency issued a $12,654.80 delivery order to Amerisourcebergen Drug Corp on April 16, 2026, for NURTEC ODT 75 mg tablets (8 count), with a final completion date of April 17, 2026. Place of performance is Conshohocken, PA. The order is firm fixed-price with no set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., and operates as a pharmaceutical distributor supplying brand-name and generic medications to the Department of Defense and federal healthcare...
- The Defense Logistics Agency issued a $13,709.00 delivery order to Amerisourcebergen Drug Corp on April 6, 2026, for NURTEC ODT 75 MG tablets (8-count), with an ultimate completion date of April 7, 2026. Place of performance is Conshohocken, PA. The order is firm fixed price with no set-aside applied. Amerisourcebergen Drug Corp operates as a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal medical procurement needs through DLA's Medical Supply Chain.
- The Defense Logistics Agency issued a $2,507.00 delivery order to Amerisourcebergen Drug Corp on April 3, 2026, for NURTEC ODT 75 mg tablets (8 count). The order is due for ultimate completion on April 6, 2026. Place of performance is Conshohocken, PA. The order carries firm fixed price terms and no set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal medical procurement needs. The awardee supplies pharmaceutical products...
- <p>The Defense Logistics Agency issued a $23,685.04 delivery order to Amerisourcebergen Drug Corp on April 2, 2026, for NURTEC ODT 75 MG tablets (8-count packaging), with ultimate completion on April 3, 2026.</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price with no set-aside applied. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., operating as a pharmaceutical distributor supplying medications and medical supplies to federal healthcare systems.</p>
- The Defense Logistics Agency issued a $16,681.35 delivery order to Amerisourcebergen Drug Corp on April 17, 2026, for NURTEC ODT 75 MG tablets (8-count). Place of performance is Conshohocken, PA. Ultimate completion date is April 20, 2026. The order is firm fixed-price with no set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. and operates as a pharmaceutical distributor supplying brand-name and generic medications, specialty pharmaceuticals, and medical devices to the...
- The Defense Logistics Agency issued a $7,635.16 delivery order to Amerisourcebergen Drug Corp on March 9, 2026, for NURTEC ODT 75 mg tablets (8-count), with an ultimate completion date of March 10, 2026. Place of performance is Conshohocken, PA. The order is issued as firm fixed price with no set-aside applied. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal medical procurement needs across the Defense Logistics Agency and other...
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 5, 2026, for NURTEC ODT 75 mg tablets (8-count packages) with a ceiling value of $8,597.82, issued under firm fixed-price pricing with no set-aside. Place of performance is Conshohocken, PA. The order has an ultimate completion date of March 6, 2026. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. and holds a $999,999,999 Indefinite Delivery Contract with DLA Troop Support Medical...
- SPE2DR25D3016Indefinite Delivery Contract
- SPE2DR25D3016-SPE2DR26FG7MSDelivery Order
The Defense Logistics Agency issued a $13,710.38 delivery order to Amerisourcebergen Drug Corp on April 23, 2026, for NURTEC ODT 75 mg tablets (8-count units), with an ultimate completion date of April 24, 2026. Place of performance is Conshohocken, PA. The order is priced on a firm fixed-price basis with no set-aside. Amerisourcebergen Drug Corp is a pharmaceutical distributor and subsidiary of Cencora, Inc., competing on full-and-open competitive awards. The company holds a single-award indefinite delivery contract (SPE2DX) with DLA valued at $4.999 million through December 2036, supporting the Pharmaceutical Prime Vendor Global Program Generation V for worldwide military healthcare supply.
Generated 7/22/26, 11:01 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.7k | 4/22/26 |